Close menu




December 3rd, 2021 | 11:48 CET

TeamViewer, Water Ways Technologies, Zooplus - Further underwater

  • agritech
Photo credits: pixabay.com

The United Nations warns of a growing imbalance in the global water balance with catastrophic consequences. Currently, two billion people live in countries without a secure drinking water supply. By 2050, the number is expected to grow to more than five billion people without adequate access to drinking water. The future belongs to companies that take care of water treatment and offer intelligent systems for water management. The TeamViewer share, on the other hand, continues to be underwater. The latest news is also not very optimistic.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: TEAMVIEWER AG INH O.N. | DE000A2YN900 , Water Ways Technologies | CA9411881043 , ZOOPLUS AG | DE0005111702

Table of contents:


    Dramatic development

    Water is our most precious commodity. According to the World Meteorological Organization (WMO), society is not in the least prepared for an impending catastrophe. Improvements are most likely to be needed in agriculture, which is responsible for around 70% of global freshwater withdrawals. Old irrigation systems should be urgently renewed. Canadian-based Water Ways Technologies has been researching the solution since 2003, providing intelligent and complex irrigation and control systems for agricultural producers.

    Originally founded in Israel, the center of agri-tech, the Company's customers are spread around the globe. With a bulging order book and orders from South America, Canada, China, Ethiopia and Mexico, Water Ways Technologies is growing dynamically. This year, the largest single order in the Company's history came from Uzbekistan, amounting to CAD 4.1 million.

    Dynamic growth

    After already reporting record results in the 1st half of the year, the Company, represented by branches in China and Israel, set yet another scent mark. In the first nine months of the fiscal year 2021, sales were pushed to a record level of CAD 15.77 million, an increase of 65% over the previous year. Revenue from service projects exploded by 258% to currently CAD 2.24 million. Gross profit also nearly doubled by 93% to CAD 2.94 million. On a positive note, record revenues were achieved both in the subsidiaries in the Middle Kingdom and Israel and at the headquarters in Canada.

    Further growth was also secured with an oversubscribed private placement of CAD 4.4 million. Future plans include expansion into other markets, such as the USA. Water Ways Technologies is growing dynamically and should be increasingly called upon to solve the problem of intelligent irrigation in the coming years. The stock market value of the Frankfurt-listed Company is currently EUR 32.70 million.

    Dive continues

    There is no end to the slide for the specialist in cloud-based solutions that enable users to collaborate online and provide remote support globally. As reported at researchanalyst.com, the company, listed in Deutsche Börse's MDAX, has had to cut its forecasts twice this fiscal year. Due to lower than expected billings and a higher cost base, the EBITDA margin is expected to be "only" 44%-46%. The revenue side has also been capped at EUR 495 million to EUR 505 million.

    The sponsoring contracts in the sports sector are putting pressure on the margin, above all the 5-year contract with the Manchester United soccer club, which the Goeppingen-based Company is paying around EUR 46 million per year for. Despite the latest Corona wave, a renewed hype about TeamViewer's software is unlikely, as everyone working in a home office and every schoolchild has already had their system set up for months. For this reason, it would not be surprising in our opinion if the even lower annual targets were to be missed again.

    Further miss and takeover?

    In this case, a further slide in the share price into the single digits would probably be the consequence. On the other hand, as reported, a takeover by software giant SAP would make perfect sense. The cooperation with TeamViewer has already started successfully, and the Walldorf-based Company lacks such software in its bulging portfolio. As reported in an interview with Handelsblatt, SAP CEO Christian Klein wants to turn the Company into one of the largest cloud companies in the world in the long term. Christiano Ronaldo wouldn't mind wearing the three letters from Walldorf on his chest when he enters Old Trafford instead of the TeamViewer logo.

    Slipped out of the index

    The sharp drop in the TeamViewer share price - at its peak, one share was worth just under EUR 50.00 - is now also impacting various index compositions. As the index provider Qontigo, which belongs to Deutsche Börse, announced on Wednesday evening, two other German companies besides TeamViewer have to say goodbye to the broad-based Stoxx Europe 600. They will no longer be listed in the index as of December 20. Both Grand City Properties and the operator of an Internet trading platform for pet supplies, Zooplus, will have to vacate their places.

    Zooplus is to disappear from the stock exchange altogether. The Munich-based company is being taken over by financial investors from Hellman & Friedman (H&F) and EQT at a valuation of EUR 3.7 billion. The delisting offer is already underway, and around 90% of shareholders have already transferred their shares. The Executive and Supervisory boards recommend that the remaining shareholders accept the delisting offer for EUR 480 per share.


    Water is our most precious resource. Water treatment and intelligent irrigation solutions should save humanity from disaster in the coming decades. Water Ways Technologies is growing dynamically and is entering the new year with a full order book. At TeamViewer, there are no signs of any easing at present.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Mario Hose on March 2nd, 2026 | 08:00 CET

    Feeding a Growing World: Bayer, K+S, and MustGrow Biologics! Mustard, as a biological innovation, is transforming the agriculture of tomorrow!

    • agritech
    • mustard
    • biologics
    • fertilizer

    Global agriculture faces mounting structural pressure. More than 8 billion people live on Earth today, and every person needs food every day. But the fields where we can grow food are getting smaller. Traditional methods of agriculture are losing acceptance, as synthetic fertilizers and chemical crop protection agents face stricter environmental oversight worldwide. That is why companies such as MustGrow Biologics, Bayer, and K+S are becoming increasingly important. These companies are working on a new type of agriculture. They are attempting to strike a balance: they aim to ensure good harvests while also protecting nature. The smaller innovator, MustGrow Biologics, exemplifies the shift toward effective biological alternatives in modern agriculture.

    Read

    Commented by Armin Schulz on February 24th, 2026 | 07:15 CET

    MustGrow Biologics and its partnership with Bayer: Why the stock is only just getting started

    • Agriculture
    • Sustainability
    • biologics
    • agritech

    Global agriculture is facing a paradox. It needs to feed more people, but with fewer chemical inputs. Worldwide, 460 pesticides are now banned or restricted across 162 countries. The era of synthetic active ingredients is coming to an end – but what comes next? A Canadian company believes it has found the answer. It grows in the field, is spicy and yellow: mustard. MustGrow Biologics has developed a technology that uses the natural defenses of the mustard plant to remediate soils and increase yields. What sounds like a niche idea could turn out to be one of the most exciting investments in the agricultural sector.

    Read

    Commented by Nico Popp on February 20th, 2026 | 07:25 CET

    Agricultural revolution breaks the billion-dollar barrier: Why MustGrow Biologics, Bayer, and Bioceres Crop Solutions are ending the era of chemicals

    • biologics
    • Agriculture
    • agritech
    • Sustainability
    • Investments

    The agricultural industry is currently transitioning from toxic chemicals to high-performance biologics. In this market environment, various players are positioning themselves with complementary strategies to capture the gigantic market for sustainable crop protection, which is expected to generate billions of dollars in revenue in the future. The ongoing deterioration of farmland and increasingly restrictive regulations are forcing farmers and corporations alike to rethink their approaches. It is no longer just about purely ecological ideals, but about food for humanity. Established agricultural giants and innovative technology companies are working feverishly to secure yields without further depleting nature. In this race, clear winners are emerging who are laying the foundation for the agriculture of the future and offering investors unprecedented opportunities. MustGrow Biologics is an exciting candidate.

    Read